Indication

Autoinflammation With Infantile Enterocolitis

1 clinical trial

2 products

Clinical trial

A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

Status: Recruiting, Estimated PCD: 2025-06-27

Product

Product